Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of HPG1860, a Structurally Novel Nonbile Acid FXR Agonist Currently in Clinical Development for the Treatment of Nonalcoholic Steatohepatitis
Cheng Mo, Xiaoqing Xu, Pan Zhang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9363-9375
Closed Access | Times Cited: 9

Showing 9 citing articles:

Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets
Joshua S. Fleishman, Sunil Kumar
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 56
Discovery of First-in-Class FXR and HSD17B13 Dual Modulator for the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease
Shixuan Jiao, Qiang Ren, Lianru Chen, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
Molecular medicinal insights into scaffold hopping-based drug discovery success
Ayan Acharya, Mukul Yadav, Mithilesh Nagpure, et al.
Drug Discovery Today (2023) Vol. 29, Iss. 1, pp. 103845-103845
Closed Access | Times Cited: 23
A Current Understanding of FXR in NAFLD: The multifaceted regulatory role of FXR and novel lead discovery for drug development
Tang Yu-hong, Yujuan Fan, Yiming Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116658-116658
Open Access | Times Cited: 8
Significance of FXR agonists in MASLD treatment: a deep dive into lipid alteration by analytical techniques
Pirangi Srikanth, Khaja Moinuddin Shaik, Vijay Patibandla, et al.
(2025) Vol. 2
Open Access
Farnesoid X receptor: From Structure to Function and Its Pharmacology in Liver Fibrosis
Chuan Hun Ding, Z. Wang, Xinyue Dou, et al.
Aging and Disease (2023)
Open Access | Times Cited: 4
Tailoring FXR Modulators for Intestinal Specificity: Recent Progress and Insights
Amanda Maria Morrison, Bahaa Elgendy
Molecules (2024) Vol. 29, Iss. 9, pp. 2022-2022
Open Access | Times Cited: 1
The discovery of a new potent FXR agonist based on natural product screening
Zongwen Yao, Lin Chen, Min Hu, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 106979-106979
Closed Access | Times Cited: 4
Discovery of 4-aminophenylacetamide derivatives as intestine-specific farnesoid X receptor antagonists for the potential treatment of nonalcoholic steatohepatitis
Cong Chen, Bing Zhang, Jiaojiao Tu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115992-115992
Closed Access | Times Cited: 4
Reacon: a template- and cluster-based framework for reaction condition prediction
Zihan Wang, Kangjie Lin, Jianfeng Pei, et al.
Chemical Science (2024)
Open Access
Page 1

Scroll to top